A Health Perspective of Hormonal Contraceptives

References

• Belsey M A. The risks and benefits of oral contraceptives in the developing world. Acta Obstet Gynecol Scand 1982, Suppl. 105: 61
   Google Scholar
• Fraser I S., Jansen R PS. Why do inadvertent pregnancies occur in oral contraceptive users?. Contraception 1983; 27: 531
   PubMedGoogle Scholar
• Aznar-Ramos R, Giner-Velazques J, Lara-Ricalde R, Martinez-Manatou J. Incidence of side effects with contraceptive placebo. Am J Obstet Gynecol 1969; 105: 1144
   PubMed Web of Science ®Google Scholar
• Goldzieher J W., Moses L E., Averkin E, Scheel C, Taber B Z. A placebo-controlled double-blind crossover investigation of the side-effects attributed to oral contraception. Fertil Steril 1971; 22: 609
   PubMed Web of Science ®Google Scholar
• Anonymous. How risky is the pill? For young women the latest evidence suggests that it isn't. The Economist April 6, 1985; 12
   Google Scholar
• Bryan J. The pill: is it ever safe for anyone?. Sunday Telegraph April 28, 1985
   Google Scholar
• Louden N B., Foxwell M, Potts D M., Guild A L., Short R V. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tricycle pill regimen. Br Med J 1977; 2: 487
   Google Scholar
• Rubin G L., Ory H W., Layde P M. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol 1982; 144: 640
   Google Scholar
• Center for Disease Control. Oral contraceptive use and the risk of endometrial cancer. JAMA 1983; 249: 1600
   Google Scholar
• Center for Disease Control. Oral contraceptive use and the risk of ovarian cancer. JAMA 1983; 249: 1596
   Google Scholar
• Royal College of General Practitioners. Oral contraceptives and health: an interim report from the oral contraception study. Pitman Medical, New York 1974
   Google Scholar
• Ramcharan S, Pellegrin F A., Ray R M., Hsu J P. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. J Reprod Med 1980; 25: 345
   PubMedGoogle Scholar
• Ory H W., Rosenfield A, Landman L S. The pill at 20: an assessment. Int Fam Plann Perspec 1980; 6: 125
   Google Scholar
• Ory H W. The health effects of fertility control. Contraception, Science, Technology and Application. Proceedings of a symposium. National Academy of Sciences, Washington, DC 1979; 110
   Google Scholar
• Shapiro S, Stone D, Rosenberg L, Kaufman D W., Stolley P D., Miettinen O S. Oral contraceptive use in relation to myocardial infarction. Lancet 1979; 1: 743
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Hennekens C H., Rosner B, Belanger C, Rothman K J., Speizer F E. Oral contraceptive use in relation to non-fatal myocardial infarction. Am J Epidemiol 1980; 111: 59
   PubMed Web of Science ®Google Scholar
• Weir R J., Briggs E, Mack A, Naismith L, Taylor L, Wilson E. Blood pressure in women taking oral contraceptives. Br Med J 1974; 533
   Google Scholar
• Fisch I R., Frank J. Oral contraceptives and blood pressure. JAMA 1977; 237: 2499
   PubMed Web of Science ®Google Scholar
• Royal College of General Practitioners. Effect on hypertension and benign breast disease of the progestogen component in oral contraceptives. Lancet 1977; 1: 624
   PubMed Web of Science ®Google Scholar
• Meade T W., Greenberg G, Thompson S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50 and 30 μg oestrogen preparations. Br Med J 1980; 1: 1157
   Google Scholar
• Jordan W M. Pulmonary embolism. Lancet 1961; 2: 1146
   Google Scholar
• Stolley P D., Tonascia J A., Jackman M S. Thrombosis with low oestrogen oral contraceptives. Am J Obstet Gynecol 1975; 102: 197
   Google Scholar
• Vessey M P. Female hormones and vascular disease—an epidemiological overview. Br J Fam Plann 1980, Suppl. 6: 1
   Google Scholar
• Barnes R W., Krapt T, Hoak J C. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives. Obstet Gynecol 1978; 51: 556
   PubMed Web of Science ®Google Scholar
• Vessey M P., Lawless M, McPherson K, Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet 1983; 2: 930
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Invasive cervical cancer and combined oral contraceptives. Br Med J 1985; 290: 961
   Google Scholar
• Varna J, Murphy G P., Aronoft B L., Baker H W. Survey of primary liver tumours and oral contraceptive use. J Toxicol Environ Health 1979; 5: 255
   Google Scholar
• Rooks R B., Ory H W., Ishak K G., Strauss L T., Greenspan J R., Hill A P., Tyler C W. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979; 24: 644
   Google Scholar
• McCredie J, Kricker A, Elliott J, Forrest J. Congenital limb defects and the pill. Lancet 1983; 2: 623
   Google Scholar
• Royal College of General Practitioners. Oral contraceptives and gall bladder disease. Lancet 1982; 2: 957
   Google Scholar
• Vessey M P., Wright N H., McPherson K, Wiggins P. Fertility after stopping different methods of contraception. Br Med J 1978; 1: 265
   PubMed Web of Science ®Google Scholar
• Hull M GR, Bromham D R., Savage P E., Jackson J AM, Jacobs H S. Normal fertility in women with post-pill amenorrhoea. Lancet 1981; 1: 1329
   Google Scholar
• Khoo S K., Correy J. Contraception and the 'high risk' woman. Med J Aust 1981; 1: 60
   PubMed Web of Science ®Google Scholar
• Fraser I S. Long acting hormonal contraceptives. Clinical Reproductive Endocrinology, R P. Shearman. Churchill Livingstone. 1985; 634
   Google Scholar
• Gray R H. Injectable contraceptives and pelvic inflammatory disease. Lancet 1985, In press
   Google Scholar
• World Health Organisation. Collaborative study of neoplasia and steroid contraceptives. Breast cancer, cervical cancer and depot medroxyprogesterone acetate. Lancet 1984; 2: 1207
   Google Scholar
• Fraser I S. Menstrual changes associated with progestogen-only contraceptives. Acta Obstet Gynecol Scand, In press, this symposium
   Google Scholar
• Howard G, Elder M G., Fotherby K. The use of nor-ethisterone oenanthate, an injectable contraceptive in patients at risk of venous thrombosis. hormones and vascular disease, R M. Greenhalgh. Pitman Medical, London 1981; 294
   Google Scholar
• Pardthaisong T, Gray R H., McDaniel E B. Return of fertility and outcome of pregnancy after discontinuation of depot medroxyprogesterone and intrauterine devices in Northern Thailand. Lancet 1980; 1: 509
   Google Scholar
• Guillebaud J. The pill. Oxford University Press. 1982
   Google Scholar
• Lawson D H. Pharmacoepidemiology: a new discipline. Br Med J 1984; 289: 940
   Google Scholar
• Venning G R. Identification of adverse reactions to new drugs. II. How were 18 important adverse reactions discovered and with what delays?. Br Med J 1983; 286: 289, 365
   Google Scholar
• Welling K, Mills A. Contraceptive trends. Br Med J 1984; 289: 939
   Google Scholar